{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:40:17Z","timestamp":1707525617219},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,11]]},"DOI":"10.7759\/cureus.52092","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T13:24:01Z","timestamp":1704979441000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Clozapine-Induced Agranulocytosis, Pharmacodynamic Synergism, and Lithium Promyelocytic Effects in Granulocyte Colony-Stimulating Factor (G-CSF) Resistance or Delayed Response: A Case Report"],"prefix":"10.7759","author":[{"given":"Philipa","family":"Owusu-Antwi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund","family":"Appiah-Kubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meheret","family":"Kinfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Gbinigie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archna","family":"Sarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind D","year":"2016","unstructured":"Siskind D, McCartney L, Goldschlager R, Kisely S. Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2016, 209:385-92. 10.1192\/bjp.bp.115.177261","journal-title":"Br J Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04215-y","article-title":"Clozapine-induced agranulocytosis","volume":"99","author":"Mijovic A","year":"2020","unstructured":"Mijovic A, MacCabe JH. Clozapine-induced agranulocytosis. Ann Hematol. 2020, 99:2477-82. 10.1007\/s00277-020-04215-y","journal-title":"Ann Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291719000369","article-title":"The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies","volume":"50","author":"Li XH","year":"2020","unstructured":"Li XH, Zhong XM, Lu L, et al.. The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies. Psychol Med. 2020, 50:583-94. 10.1017\/S0033291719000369","journal-title":"Psychol Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000715","article-title":"Clozapine-associated agranulocytosis treatment with granulocyte colony-stimulating factor\/granulocyte-macrophage colony-stimulating factor: a systematic review","volume":"37","author":"Lally J","year":"2017","unstructured":"Lally J, Malik S, Whiskey E, et al.. Clozapine-associated agranulocytosis treatment with granulocyte colony-stimulating factor\/granulocyte-macrophage colony-stimulating factor: a systematic review. J Clin Psychopharmacol. 2017, 37:441-6. 10.1097\/JCP.0000000000000715","journal-title":"J Clin Psychopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1192\/pb.29.5.186","article-title":"Managing clozapine-induced neutropenia with lithium","volume":"29","author":"Paton C","year":"2005","unstructured":"Paton C, Esop R. Managing clozapine-induced neutropenia with lithium. Psychiatri Bull. 2005, 29:186-8. 10.1192\/pb.29.5.186","journal-title":"Psychiatri Bull"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12193","article-title":"Practitioner attitudes to clozapine initiation","volume":"130","author":"Gee S","year":"2014","unstructured":"Gee S, Vergunst F, Howes O, Taylor D. Practitioner attitudes to clozapine initiation. Acta Psychiatr Scand. 2014, 130:16-24. 10.1111\/acps.12193","journal-title":"Acta Psychiatr Scand"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2019-100172","article-title":"Delaying clozapine: how long is too long?","volume":"33","author":"Varghese M T","year":"2020","unstructured":"Varghese M T, Jyothi KS, Shaji KS, Rita Venugopal L. Delaying clozapine: how long is too long?. Gen Psychiatr. 2020, 33:e100172. 10.1136\/gpsych-2019-100172","journal-title":"Gen Psychiatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201500507","article-title":"The business case for expanded clozapine utilization","volume":"67","author":"G\u00f6ren JL","year":"2016","unstructured":"G\u00f6ren JL, Rose AJ, Smith EG, Ney JP. The business case for expanded clozapine utilization. Psychiatr Serv. 2016, 67:1197-205. 10.1176\/appi.ps.201500507","journal-title":"Psychiatr Serv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-022-00281-9","article-title":"Pharmacogenomics of clozapine-induced agranulocytosis: a systematic review and meta-analysis","volume":"22","author":"Islam F","year":"2022","unstructured":"Islam F, Hain D, Lewis D, Law R, Brown LC, Tanner JA, M\u00fcller DJ. Pharmacogenomics of clozapine-induced agranulocytosis: a systematic review and meta-analysis. Pharmacogenomics J. 2022, 22:230-40. 10.1038\/s41397-022-00281-9","journal-title":"Pharmacogenomics J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-04659-2","article-title":"Valproate-related neutropenia and lithium-related leukocytosis in patients treated with clozapine: a retrospective cohort study","volume":"23","author":"Yang CC","year":"2023","unstructured":"Yang CC, Wang XY, Chou PH, Lin CH. Valproate-related neutropenia and lithium-related leukocytosis in patients treated with clozapine: a retrospective cohort study. BMC Psychiatry. 2023, 23:170. 10.1186\/s12888-023-04659-2","journal-title":"BMC Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91625-I","article-title":"Rechallenge in clozapine-induced agranulocytosis","volume":"339","author":"Safferman A","year":"1992","unstructured":"Safferman A, Lieberman J, Alvir JoseMaJ, Howard A. Rechallenge in clozapine-induced agranulocytosis. Lancet. 1992, 339:1296-7. 10.1016\/0140-6736(92)91625-I","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.188.3.255","article-title":"Rechallenge with clozapine following leucopenia or neutropenia during previous therapy","volume":"188","author":"Dunk LR","year":"2006","unstructured":"Dunk LR, Annan LJ, Andrews CD. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy. Br J Psychiatry. 2006, 188:255-63. 10.1192\/bjp.188.3.255","journal-title":"Br J Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/pu.30889","article-title":"Prolonged agranulocytosis with clozapine despite colony-stimulating factor treatment","volume":"33","author":"Lam YW","year":"2022","unstructured":"Lam YW. Prolonged agranulocytosis with clozapine despite colony-stimulating factor treatment. Brown Univ Psychopharmacol update. 2022, 33:2-3. 10.1002\/pu.30889","journal-title":"Brown Univ Psychopharmacol update"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)91155-X","article-title":"Lithium-induced hematologic changes in patients with bipolar affective disorder","volume":"35","author":"\u00d6zdemir MA","year":"1994","unstructured":"\u00d6zdemir MA, Sofuo\u011flu S, Tanrikulu G, Aldanmaz F, E\u015fel E, D\u00fcndar S. Lithium-induced hematologic changes in patients with bipolar affective disorder. Biol Psychiatry. 1994, 35:210-3. 10.1016\/0006-3223(94)91155-X","journal-title":"Biol Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.07111823","article-title":"Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia","volume":"165","author":"Ghaznavi S","year":"2008","unstructured":"Ghaznavi S, Nakic M, Rao P, Hu J, Brewer JA, Hannestad J, Bhagwagar Z. Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia. Am J Psychiatry. 2008, 165:813-8. 10.1176\/appi.ajp.2008.07111823","journal-title":"Am J Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/196970-severe-clozapine-induced-agranulocytosis-pharmacodynamic-synergism-and-lithium-promyelocytic-effects-in-granulocyte-colony-stimulating-factor-g-csf-resistance-or-delayed-response-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:22Z","timestamp":1707509482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/196970-severe-clozapine-induced-agranulocytosis-pharmacodynamic-synergism-and-lithium-promyelocytic-effects-in-granulocyte-colony-stimulating-factor-g-csf-resistance-or-delayed-response-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.52092","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,11]]}}}